Name | Prostate-specific antigen | ||
UniProt ID | KLK3_HUMAN | ||
Gene Name | KLK3 | ||
Gene ID | 354 | ||
Synonyms |
KLK3, APS, KLK2A1, PSA, hK3
|
||
Sequence |
MWVPVVFLTLSVTWIGAAPLILSRIVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWV
LTAAHCIRNKSVILLGRHSLFHPEDTGQVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHD LMLLRLSEPAELTDAVKVMDLPTQEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVIS NDVCAQVHPQKVTKFMLCAGRWTGGKSTCSGDSGGPLVCNGVLQGITSWGSEPCALPERP SLYTKVVHYRKWIKDTIVANP |
||
Pathway Map | MAP LINK | ||
T.C. Number | 8.A.131.1.5; 8.A.131.1.6 | ||
KEGG ID | hsa354 | ||
TTD ID | T36935 | ||
Pfam | PF00089; PF08517; PF09342; PF13365 |
Pair Name | Noscapine, Paclitaxel | |||
Phytochemical | Noscapine | |||
Drug | Paclitaxel | |||
Disease Info | [ICD-11: 2C82] | Prostate cancer | Investigative | |
Regulate Info | Down-regulation | Prostate-specific antigen | Expression | |
Result | This study provides a novel concept of combination treatment of paclitaxel and noscapine to improve efficiency in human prostate cancer treatment. |